APO Research
Talk to an analyst

APO RESEARCH · REPORT

Angiotensin II Receptor

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Angiotensin II Receptor Market Outlook and Growth Opportunities 2026

22 December 2025192 pages

Choose your research edition.

Industry ResearchAngiotensin II Receptor Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiotensin II Receptor Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Angiotensin II Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiotensin II Receptor Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiotensin II Receptor Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Angiotensin II Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Angiotensin II Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Angiotensin II Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiotensin II Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Angiotensin II Receptor market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Angiotensin II Receptor market include CJ HealthCare Corp, MorphoSys AG, Vicore Pharma AB and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Angiotensin II Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Angiotensin II Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Angiotensin II Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Angiotensin II Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Angiotensin II Receptor Segment by Company

CJ HealthCare Corp

MorphoSys AG

Vicore Pharma AB

Novartis AG

Angiotensin II Receptor Segment by Type

MOR-107

KDT-501

EMA-401

C-21

Others

Angiotensin II Receptor Segment by Application

Women's Health

Immunology

Acute Ischemic Stroke

Respiratory

Others

Angiotensin II Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Angiotensin II Receptor status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Angiotensin II Receptor market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Angiotensin II Receptor significant trends, drivers, influence factors in global and regions.

6. To analyze Angiotensin II Receptor competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Angiotensin II Receptor market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Angiotensin II Receptor industry.

Chapter 3: Detailed analysis of Angiotensin II Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Angiotensin II Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Angiotensin II Receptor in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Angiotensin II Receptor Industry Trends Table 2. Angiotensin II Receptor Industry Drivers Table 3. Angiotensin II Receptor Industry Opportunities and Challenges Table 4. Angiotensin II Receptor Industry Restraints Table 5. Global Angiotensin II Receptor Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Angiotensin II Receptor Revenue Share by Company (2021-2026) Table 7. Global Angiotensin II Receptor Sales Volume by Company (k units) & (2021-2026) Table 8. Global Angiotensin II Receptor Sales Volume Share by Company (2021-2026) Table 9. Global Angiotensin II Receptor Average Price (US$/unit) of Company (2021-2026) Table 10. Global Angiotensin II Receptor Company Ranking, (2024-2026) & (USD Million) Table 11. Global Angiotensin II Receptor Key Company Manufacturing Base & Headquarters Table 12. Global Angiotensin II Receptor Company, Product Type & Application Table 13. Global Angiotensin II Receptor Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Angiotensin II Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of MOR-107 Table 18. Significant Companies of KDT-501 Table 19. Significant Companies of EMA-401 Table 20. Significant Companies of C-21 Table 21. Significant Companies of Others Table 22. Global Angiotensin II Receptor Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Angiotensin II Receptor Sales Volume by Type (2021-2026) & (k units) Table 24. Global Angiotensin II Receptor Sales Volume by Type (2027-2032) & (k units) Table 25. Global Angiotensin II Receptor Sales Volume Share by Type (2021-2026) Table 26. Global Angiotensin II Receptor Sales Volume Share by Type (2027-2032) Table 27. Global Angiotensin II Receptor Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Angiotensin II Receptor Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Angiotensin II Receptor Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Angiotensin II Receptor Sales Value Share by Type (2021-2026) Table 31. Global Angiotensin II Receptor Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Women's Health Table 33. Significant Companies of Immunology Table 34. Significant Companies of Acute Ischemic Stroke Table 35. Significant Companies of Respiratory Table 36. Significant Companies of Others Table 37. Global Angiotensin II Receptor Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Angiotensin II Receptor Sales Volume by Application (2021-2026) & (k units) Table 39. Global Angiotensin II Receptor Sales Volume by Application (2027-2032) & (k units) Table 40. Global Angiotensin II Receptor Sales Volume Share by Application (2021-2026) Table 41. Global Angiotensin II Receptor Sales Volume Share by Application (2027-2032) Table 42. Global Angiotensin II Receptor Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Angiotensin II Receptor Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Angiotensin II Receptor Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Angiotensin II Receptor Sales Value Share by Application (2021-2026) Table 46. Global Angiotensin II Receptor Sales Value Share by Application (2027-2032) Table 47. Global Angiotensin II Receptor Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Angiotensin II Receptor Sales by Region (2021-2026) & (k units) Table 49. Global Angiotensin II Receptor Sales Market Share by Region (2021-2026) Table 50. Global Angiotensin II Receptor Sales by Region (2027-2032) & (k units) Table 51. Global Angiotensin II Receptor Sales Market Share by Region (2027-2032) Table 52. Global Angiotensin II Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Angiotensin II Receptor Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Angiotensin II Receptor Sales Value Share by Region (2021-2026) Table 55. Global Angiotensin II Receptor Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Angiotensin II Receptor Sales Value Share by Region (2027-2032) Table 57. Global Angiotensin II Receptor Market Average Price (US$/unit) by Region (2021-2026) Table 58. Global Angiotensin II Receptor Market Average Price (US$/unit) by Region (2027-2032) Table 59. Global Angiotensin II Receptor Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 60. Global Angiotensin II Receptor Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 62. Global Angiotensin II Receptor Sales Market Share by Country (2021-2026) Table 63. Global Angiotensin II Receptor Sales by Country (2027-2032) & (k units) Table 64. Global Angiotensin II Receptor Sales Market Share by Country (2027-2032) Table 65. Global Angiotensin II Receptor Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Angiotensin II Receptor Sales Value Market Share by Country (2021-2026) Table 67. Global Angiotensin II Receptor Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Angiotensin II Receptor Sales Value Market Share by Country (2027-2032) Table 69. CJ HealthCare Corp Company Information Table 70. CJ HealthCare Corp Business Overview Table 71. CJ HealthCare Corp Angiotensin II Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. CJ HealthCare Corp Angiotensin II Receptor Product Portfolio Table 73. CJ HealthCare Corp Recent Development Table 74. MorphoSys AG Company Information Table 75. MorphoSys AG Business Overview Table 76. MorphoSys AG Angiotensin II Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. MorphoSys AG Angiotensin II Receptor Product Portfolio Table 78. MorphoSys AG Recent Development Table 79. Vicore Pharma AB Company Information Table 80. Vicore Pharma AB Business Overview Table 81. Vicore Pharma AB Angiotensin II Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Vicore Pharma AB Angiotensin II Receptor Product Portfolio Table 83. Vicore Pharma AB Recent Development Table 84. Novartis AG Company Information Table 85. Novartis AG Business Overview Table 86. Novartis AG Angiotensin II Receptor Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Novartis AG Angiotensin II Receptor Product Portfolio Table 88. Novartis AG Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Angiotensin II Receptor Distributors List Table 92. Angiotensin II Receptor Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Angiotensin II Receptor Product Image Figure 2. Global Angiotensin II Receptor Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiotensin II Receptor Sales Value (2021-2032) & (US$ Million) Figure 4. Global Angiotensin II Receptor Sales (2021-2032) & (k units) Figure 5. Global Angiotensin II Receptor Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Angiotensin II Receptor Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. MOR-107 Image Figure 10. KDT-501 Image Figure 11. EMA-401 Image Figure 12. C-21 Image Figure 13. Others Image Figure 14. Global Angiotensin II Receptor Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Angiotensin II Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Angiotensin II Receptor Sales Volume Share by Type (2021-2032) Figure 17. Global Angiotensin II Receptor Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Angiotensin II Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Angiotensin II Receptor Sales Value Share by Type (2021-2032) Figure 20. Women's Health Image Figure 21. Immunology Image Figure 22. Acute Ischemic Stroke Image Figure 23. Respiratory Image Figure 24. Others Image Figure 25. Global Angiotensin II Receptor Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Angiotensin II Receptor Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Angiotensin II Receptor Sales Volume Share by Application (2021-2032) Figure 28. Global Angiotensin II Receptor Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Angiotensin II Receptor Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Angiotensin II Receptor Sales Value Share by Application (2021-2032) Figure 31. Global Angiotensin II Receptor Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 32. Global Angiotensin II Receptor Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Angiotensin II Receptor Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Angiotensin II Receptor Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Angiotensin II Receptor Sales Value (2021-2032) & (US$ Million) Figure 36. North America Angiotensin II Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Angiotensin II Receptor Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Angiotensin II Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Angiotensin II Receptor Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Angiotensin II Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Angiotensin II Receptor Sales Value (2021-2032) & (US$ Million) Figure 42. South America Angiotensin II Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Angiotensin II Receptor Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Angiotensin II Receptor Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Angiotensin II Receptor Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Angiotensin II Receptor Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Angiotensin II Receptor Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • MOR-107
  • KDT-501
  • EMA-401
  • C-21
  • Others
Applications
  • Women's Health
  • Immunology
  • Acute Ischemic Stroke
  • Respiratory
  • Others
Companies covered
  • CJ HealthCare Corp
  • MorphoSys AG
  • Vicore Pharma AB
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Angiotensin II Receptor Sales Value (2021-2032)
  4. 1.2.2 Global Angiotensin II Receptor Sales Volume (2021-2032)
  5. 1.2.3 Global Angiotensin II Receptor Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Angiotensin II Receptor Market Dynamics
  1. 2.1 Angiotensin II Receptor Industry Trends
  2. 2.2 Angiotensin II Receptor Industry Drivers
  3. 2.3 Angiotensin II Receptor Industry Opportunities and Challenges
  4. 2.4 Angiotensin II Receptor Industry Restraints
3 Angiotensin II Receptor Market by Company
  1. 3.1 Global Angiotensin II Receptor Company Revenue Ranking in 2025
  2. 3.2 Global Angiotensin II Receptor Revenue by Company (2021-2026)
  3. 3.3 Global Angiotensin II Receptor Sales Volume by Company (2021-2026)
  4. 3.4 Global Angiotensin II Receptor Average Price by Company (2021-2026)
  5. 3.5 Global Angiotensin II Receptor Company Ranking (2024-2026)
  6. 3.6 Global Angiotensin II Receptor Company Manufacturing Base and Headquarters
  7. 3.7 Global Angiotensin II Receptor Company Product Type and Application
  8. 3.8 Global Angiotensin II Receptor Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Angiotensin II Receptor Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Angiotensin II Receptor Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Angiotensin II Receptor Market by Type
  1. 4.1 Angiotensin II Receptor Type Introduction
  2. 4.1.1 MOR-107
  3. 4.1.2 KDT-501
  4. 4.1.3 EMA-401
  5. 4.1.4 C-21
  6. 4.1.5 Others
  7. 4.2 Global Angiotensin II Receptor Sales Volume by Type
  8. 4.2.1 Global Angiotensin II Receptor Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Angiotensin II Receptor Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Angiotensin II Receptor Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Angiotensin II Receptor Sales Value by Type
  12. 4.3.1 Global Angiotensin II Receptor Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Angiotensin II Receptor Sales Value by Type (2021-2032)
  14. 4.3.3 Global Angiotensin II Receptor Sales Value Share by Type (2021-2032)
5 Angiotensin II Receptor Market by Application
  1. 5.1 Angiotensin II Receptor Application Introduction
  2. 5.1.1 Women's Health
  3. 5.1.2 Immunology
  4. 5.1.3 Acute Ischemic Stroke
  5. 5.1.4 Respiratory
  6. 5.1.5 Others
  7. 5.2 Global Angiotensin II Receptor Sales Volume by Application
  8. 5.2.1 Global Angiotensin II Receptor Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Angiotensin II Receptor Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Angiotensin II Receptor Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Angiotensin II Receptor Sales Value by Application
  12. 5.3.1 Global Angiotensin II Receptor Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Angiotensin II Receptor Sales Value by Application (2021-2032)
  14. 5.3.3 Global Angiotensin II Receptor Sales Value Share by Application (2021-2032)
6 Angiotensin II Receptor Regional Sales and Value Analysis
  1. 6.1 Global Angiotensin II Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Angiotensin II Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Angiotensin II Receptor Sales by Region: 2021-2026
  4. 6.2.2 Global Angiotensin II Receptor Sales by Region (2027-2032)
  5. 6.3 Global Angiotensin II Receptor Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Angiotensin II Receptor Sales Value by Region (2021-2032)
  7. 6.4.1 Global Angiotensin II Receptor Sales Value by Region: 2021-2026
  8. 6.4.2 Global Angiotensin II Receptor Sales Value by Region (2027-2032)
  9. 6.5 Global Angiotensin II Receptor Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Angiotensin II Receptor Sales Value (2021-2032)
  12. 6.6.2 North America Angiotensin II Receptor Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Angiotensin II Receptor Sales Value (2021-2032)
  15. 6.7.2 Europe Angiotensin II Receptor Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Angiotensin II Receptor Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Angiotensin II Receptor Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Angiotensin II Receptor Sales Value (2021-2032)
  21. 6.9.2 South America Angiotensin II Receptor Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Angiotensin II Receptor Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Angiotensin II Receptor Sales Value Share by Country, 2025 VS 2032
7 Angiotensin II Receptor Country-level Sales and Value Analysis
  1. 7.1 Global Angiotensin II Receptor Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Angiotensin II Receptor Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Angiotensin II Receptor Sales by Country (2021-2032)
  4. 7.3.1 Global Angiotensin II Receptor Sales by Country (2021-2026)
  5. 7.3.2 Global Angiotensin II Receptor Sales by Country (2027-2032)
  6. 7.4 Global Angiotensin II Receptor Sales Value by Country (2021-2032)
  7. 7.4.1 Global Angiotensin II Receptor Sales Value by Country (2021-2026)
  8. 7.4.2 Global Angiotensin II Receptor Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Angiotensin II Receptor Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Angiotensin II Receptor Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Angiotensin II Receptor Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CJ HealthCare Corp
  2. 8.1.1 CJ HealthCare Corp Company Information
  3. 8.1.2 CJ HealthCare Corp Business Overview
  4. 8.1.3 CJ HealthCare Corp Angiotensin II Receptor Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CJ HealthCare Corp Angiotensin II Receptor Product Portfolio
  6. 8.1.5 CJ HealthCare Corp Recent Developments
  7. 8.2 MorphoSys AG
  8. 8.2.1 MorphoSys AG Company Information
  9. 8.2.2 MorphoSys AG Business Overview
  10. 8.2.3 MorphoSys AG Angiotensin II Receptor Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 MorphoSys AG Angiotensin II Receptor Product Portfolio
  12. 8.2.5 MorphoSys AG Recent Developments
  13. 8.3 Vicore Pharma AB
  14. 8.3.1 Vicore Pharma AB Company Information
  15. 8.3.2 Vicore Pharma AB Business Overview
  16. 8.3.3 Vicore Pharma AB Angiotensin II Receptor Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vicore Pharma AB Angiotensin II Receptor Product Portfolio
  18. 8.3.5 Vicore Pharma AB Recent Developments
  19. 8.4 Novartis AG
  20. 8.4.1 Novartis AG Company Information
  21. 8.4.2 Novartis AG Business Overview
  22. 8.4.3 Novartis AG Angiotensin II Receptor Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis AG Angiotensin II Receptor Product Portfolio
  24. 8.4.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Angiotensin II Receptor Value Chain Analysis
  2. 9.1.1 Angiotensin II Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Angiotensin II Receptor Sales Mode & Process
  6. 9.2 Angiotensin II Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Angiotensin II Receptor Distributors
  9. 9.2.3 Angiotensin II Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst